Paul A. Bunn
Department of Medicine
University of Colorado Cancer Center and University of Colorado Health Sciences Center
Aurora
80045
USA
Name/email consistency: high
- Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy. Bunn, P.A., Dziadziuszko, R., Varella-Garcia, M., Franklin, W.A., Witta, S.E., Kelly, K., Hirsch, F.R. Clin. Cancer Res. (2006)
- The potential role of proteasome inhibitors in the treatment of lung cancer. Bunn, P.A. Clin. Cancer Res. (2004)
- New investigative regimens and cytotoxic agents in thoracic cancers: gemcitabine and pemetrexed. Bunn, P. Oncology (Williston Park, N.Y.) (2004)
- Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy. Bunn, P.A. Clin. Lung. Cancer (2004)
- Early-stage NSCLC: the role of radiotherapy and systemic therapy. Bunn, P.A. J. Natl. Compr. Canc. Netw (2004)
- Ongoing and future trials of biologic therapies in lung cancer. Bunn, P.A., Shepherd, F.A., Sandler, A., Le Chevalier, T., Belani, C.P., Kosmidis, P.A., Scagliotti, G.V., Giaccone, G. Lung. Cancer (2003)
- Implementing ASCO's strategic plan 2003: diverse membership needs, prevention, and patient partnerships. Bunn, P.A. J. Clin. Oncol. (2003)
- Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why?. Bunn, P.A. J. Clin. Oncol. (2002)
- Molecular biology and early diagnosis in lung cancer. Bunn, P.A. Lung. Cancer (2002)
- The role of irinotecan combined with Cisplatin or Carboplatin in the treatment of advanced non-small-cell lung cancer. Bunn, P.A. Clin. Lung. Cancer (2002)
- The future of cyclooxygenase-2 inhibitors and other inhibitors of the eicosanoid signal pathway in the prevention and therapy of lung cancer. Bunn, P.A., Keith, R.L. Clin. Lung. Cancer (2002)
- Irinotecan and platinums in the treatment of non small-cell lung cancer. Bunn, P.A. Clin. Lung. Cancer (2001)
- Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer: a time for reassessment?. Bunn, P.A., Mault, J., Kelly, K. Chest (2000)
- New combinations in the treatment of lung cancer: a time for optimism. Bunn, P.A., Kelly, K. Chest (2000)
- New therapeutic strategies for lung cancer: biology and molecular biology come of age. Bunn, P.A., Soriano, A., Johnson, G., Heasley, L. Chest (2000)
- Combinations of three chemotherapeutic agents and two chemotherapeutic agents plus a targeted biologic agent in the treatment of advanced non small-cell lung cancer. Bunn, P.A., Kelly, K. Clin. Lung. Cancer (2000)
- Immune therapy for lung cancer: are we getting closer?. Bunn, P.A. Am. J. Respir. Cell Mol. Biol. (1999)
- Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo. Bunn, P.A., Helfrich, B.A., Brenner, D.G., Chan, D.C., Dykes, D.J., Cohen, A.J., Miller, Y.E. Clin. Cancer Res. (1998)